Biological factors in obsessive-compulsive disorders.
Turner
S M
SM
Beidel
D C
DC
Nathan
R S
RS
D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001143:Arousal / Q000502:physiology; D001921:Brain / Q000503:physiopathology*; D003907:Dexamethasone; D004569:Electroencephalography; D005074:Evoked Potentials, Visual; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D009771:Obsessive-Compulsive Disorder / Q000453:epidemiology / Q000503:physiopathology* / Q000628:therapy; D011612:Psychosurgery; D011930:Reaction Time / Q000502:physiology; D012890:Sleep / Q000502:physiology
D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D007980:Levodopa; D003907:Dexamethasone